相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Telmisartan on Preventing Learning and Memory Deficits Via Peroxisome Proliferator-Activated Receptor-γ in Vascular Dementia Spontaneously Hypertensive Rats
Yuan Gao et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Effect of Telmisartan on Preventing Learning and Memory Deficits Via Peroxisome Proliferator-Activated Receptor-γ in Vascular Dementia Spontaneously Hypertensive Rats
Yuan Gao et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling
Shawqi H. Alawdi et al.
MOLECULAR NEUROBIOLOGY (2017)
Protective effect of citicoline against aluminum-induced cognitive impairments in rats
Ahmed O. Abdel-Zaher et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2017)
Protective effects of telmisartan and tempol on lipopolysaccharide-induced cognitive impairment, neuroinflammation, and amyloidogenesis: possible role of brain-derived neurotrophic factor
Waleed A. I. Khallaf et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2017)
Tannoid principles of Emblica officinalis renovate cognitive deficits and attenuate amyloid pathologies against aluminum chloride induced rat model of Alzheimer's disease
Arokiasamy Justin Thenmozhi et al.
NUTRITIONAL NEUROSCIENCE (2016)
Bone Marrow-Derived Endothelial Progenitor Cells Protect Against Scopolamine-Induced Alzheimer-Like Pathological Aberrations
Marwa M. Safar et al.
MOLECULAR NEUROBIOLOGY (2016)
Protective effect of a calcium channel blocker diltiazem on aluminum chloride-induced dementia in mice
Anu Rani et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
Telmisartan mediates anti-inflammatory and not cognitive function through PPAR-γ agonism via SARM and MyD88 signaling
S. Prathab Balaji et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress
Dominik Wincewicz et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2015)
Long-term Effect of Telmisartan on Alzheimer's Amyloid Genesis in SHR-SR After tMCAO
Tomoko Kurata et al.
TRANSLATIONAL STROKE RESEARCH (2015)
Telmisartan Treatment Ameliorates Memory Deficits in Streptozotocin-Induced Diabetic Mice via Attenuating Cerebral Amyloidosis
Guan Tao Du et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
Telmisartan Reduces Progressive Accumulation of Cellular Amyloid Beta and Phosphorylated Tau with Inflammatory Responses in Aged Spontaneously Hypertensive Stroke Resistant Rat
Tomoko Kurata et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation
Juan Wang et al.
NEUROPHARMACOLOGY (2014)
Telmisartan attenuates cognitive impairment caused by chronic stress in rats
Dominik Wincewicz et al.
PHARMACOLOGICAL REPORTS (2014)
Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation
Amira Zaky et al.
BMC NEUROSCIENCE (2013)
Captopril and telmisartan treatments attenuate cadmium-induced testicular toxicity in rats
Amr A. Fouad et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2013)
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property
Birdavinder Singh et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2013)
Activation of the NF-κB Pathway by the STAT3 Inhibitor JSI-124 in Human Glioblastoma Cells
Braden C. McFarland et al.
MOLECULAR CANCER RESEARCH (2013)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
The Preventive and Therapeutic Effects of Intravenous Human Adipose-Derived Stem Cells in Alzheimer's Disease Mice
Saeromi Kim et al.
PLOS ONE (2012)
Experimental hypertension induced vascular dementia: Pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor
Bhupesh Sharma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Jose Miguel Rubio-Perez et al.
SCIENTIFIC WORLD JOURNAL (2012)
Angiotensin II Activation of mTOR Results in Tubulointerstitial Fibrosis through Loss of N-Cadherin
Adam Whaley-Connell et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Angiotensin II, Oxidative Stress and Skeletal Muscle Wasting
Sergiy Sukhanov et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage
Masatsugu Horiuchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Amyloid β-Mediated Cell Death of Cultured Hippocampal Neurons Reveals Extensive Tau Fragmentation without Increased Full-length Tau Phosphorylation
Jack Reifert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease
Rupinder K. Sodhi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Changes in cognition
Marilyn S. Albert
NEUROBIOLOGY OF AGING (2011)
Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Activation Confers Functional Neuroprotection in Global Ischemia
Zahra Fatehi-Hassanabad et al.
NEUROTOXICITY RESEARCH (2011)
Peroxisome Proliferator-Activated Receptor-Gamma Expression in the Lung Tissue of Obese Rats
Su Jin Hwang et al.
YONSEI MEDICAL JOURNAL (2011)
Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia
Yukiko Kasahara et al.
BRAIN RESEARCH (2010)
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease
Koji Yamada et al.
BRAIN RESEARCH (2010)
The nuclear factor-kappa B-interleukin-6 signalling pathway mediating vascular inflammation
Allan R. Brasier
CARDIOVASCULAR RESEARCH (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ AGONISTS AS NEUROPROTECTIVE AGENTS
Ravinder K. Kaundal et al.
DRUG NEWS & PERSPECTIVES (2010)
Role of Oxidative Stress in the Progression of Alzheimer's Disease
Rukhsana Sultana et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Oxidative Balance in Alzheimer's Disease: Relationship to APOE, Braak Tangle Stage, and the Concentrations of Soluble and Insoluble Amyloid-beta
Hannah Tayler et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain
Torben Glatz et al.
JOURNAL OF HYPERTENSION (2010)
Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion
Kazuo Washida et al.
STROKE (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Effect of N-Acetyl Cysteine against Aluminium-induced Cognitive Dysfunction and Oxidative Damage in Rats
Atish Prakash et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats
Anil Kumar et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Cognitive Deficit in Amyloid-β-Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
Kana Tsukuda et al.
HYPERTENSION (2009)
Telmisartan inhibits cytokine-induced nuclear factor-κB activation independently of the peroxisome proliferator-activated receptor-γ
Ayuko Nakano et al.
HYPERTENSION RESEARCH (2009)
Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor γ-dependent mechanism
Tamami Haraguchi et al.
NEUROSCIENCE LETTERS (2009)
Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease
Touqeer Ahmed et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
NF-κB as a Critical Link Between Inflammation and Cancer
Michael Karin
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist
Nektaria Nicolakakis et al.
JOURNAL OF NEUROSCIENCE (2008)
Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats
D. Kumaran et al.
NEUROSCIENCE (2008)
PPARγ agonists as therapeutics for the treatment of Alzheimer's disease
Gary Landreth et al.
NEUROTHERAPEUTICS (2008)
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral Hemorrhage
Keun-Hwa Jung et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Therapeutic use of agonists of the nuclear receptor PPARγ in Alzheimer's disease
Gary Landreth
CURRENT ALZHEIMER RESEARCH (2007)
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Patrick G. Kehoe et al.
LANCET NEUROLOGY (2007)
The effect of sulfur dioxide inhalation on active avoidance learning, antioxidant status and lipid peroxidation during aging
Piraye Yargicoglu et al.
NEUROTOXICOLOGY AND TERATOLOGY (2007)
The CNS renin-angiotensin system
O. von Bohlen und Halbach et al.
CELL AND TISSUE RESEARCH (2006)
Angiotensin II disrupts inhibitory avoidance memory retrieval
Juliana S. Bonini et al.
HORMONES AND BEHAVIOR (2006)
Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
Kon Chu et al.
BRAIN RESEARCH (2006)
A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model
Bharathi et al.
BRAIN RESEARCH REVIEWS (2006)
Peripheral cholinergic disturbances in Alzheimer's disease
Z Rakonczay et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2005)
The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain
PN Moynagh
JOURNAL OF ANATOMY (2005)
Aluminum-triggered structural modifications and aggregation of β-amyloids
F Ricchelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
The generation of a 17 kDa neurotoxic fragment:: An alternative mechanism by which tau mediates β-amyloid-induced neurodegeneration
SY Park et al.
JOURNAL OF NEUROSCIENCE (2005)
Amyloid-β peptide triggers Fas-independent apoptosis and differentiation of neural progenitor cells
P Millet et al.
NEUROBIOLOGY OF DISEASE (2005)
Aging, stress and the hippocampus
DB Miller et al.
AGEING RESEARCH REVIEWS (2005)
Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism
DS Kerr et al.
PSYCHOPHARMACOLOGY (2005)
Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation
L Minghetti et al.
BRAIN RESEARCH REVIEWS (2005)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
Alzheimer's disease pathogenesis and therapeutic interventions
MS Parihar et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2004)
Amyloid precursor protein, presenilins, and α-synuclein:: Molecular pathogenesis and pharmacological applications in Alzheimer's disease
YH Suh et al.
PHARMACOLOGICAL REVIEWS (2002)
Lipid peroxidation and protein oxidation in Alzheimer's disease brain:: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress
DA Butterfield et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice
D Praticó et al.
FASEB JOURNAL (2002)
Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory
PM Wall et al.
PSYCHOPHARMACOLOGY (2002)
β-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand
Y Morishima et al.
JOURNAL OF NEUROSCIENCE (2001)
Aluminium toxicity in the rat brain: Histochemical and immunocytochemical evidence
B Platt et al.
BRAIN RESEARCH BULLETIN (2001)
Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of β-amyloid protein
M Kawahara et al.
BRAIN RESEARCH BULLETIN (2001)
Aluminium toxicokinetics: An updated MiniReview
RA Yokel et al.
PHARMACOLOGY & TOXICOLOGY (2001)
Aluminum increases levels of β-amyloid and ubiquitin in neuroblastoma but not in glioma cells
A Campbell et al.
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
分享论文
